Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by Bungeon Nov 23, 2020 8:42am

864 Views

Post# 31951123

L2

Level two quotes - Ask
Ask Price	Number of Shares
0.190	75,000	75,000 shares
0.195	24,000	24,000 shares
0.200	16,500	16,500 shares
0.205	15,000	15,000 shares
0.220	138,500	138,500 shares
0.225	30,000	30,000 shares
0.230	14,500	14,500 shares
0.235	7,500	7,500 shares
0.240	36,000	36,000 shares
0.245	25,000

Number of Shares		Bid Price
67,000 shares	67,000	0.190
22,000 shares	22,000	0.160
15,000 shares	15,000	0.155
87,000 shares	87,000	0.150
135,000 shares	135,000	0.145
130,000 shares	130,000	0.140
45,000 shares	45,000	0.135
34,000 shares	34,000	0.130
100,000 shares	100,000	0.125
18,500 shares	18,500	0.120